Skip to main content
Premium Trial:

Request an Annual Quote

Signature Diagnostics Licenses Genedata s Expressionist Tool

NEW YORK, Nov. 1 (GenomeWeb News) - Genedata has licensed its Expressionist tool to Signature Diagnostics to create gene profiles in colorectal cancer patients, Genedata said today.


Signature Diagnostics will use the Expressionist software to process and analyze Affymetrix GeneChip data from thousands of CRC patients currently receiving treatment, Genedata said. The goal is to identify unique gene-expression signatures that predict the risk of recurrence and response to therapy of individual patients.


Signature Diagnostics, based in Potsdam, Germany, collaborates with clinical partners to improve the clinical development of oncology drugs and develops molecular diagnostics for predicting outcome and drug response in cancer patients.


Additional details for the licensing agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.